Prognosis and treatment of macular bleeding in neovascular age-related macular degeneration

被引：0
作者：
Agostini, H. T. [1 ]
Bopp, S. [2 ]
Feltgen, N. [3 ]
机构：
[1] Univ Klinikum Freiburg, Klin Augenheilkunde, Killianstr 5, D-79106 Freiburg, Germany
[2] Tagesklin, Augenabt, Univ Allee, Bremen, Germany
[3] Univ Klinikum Gottingen, Univ Augenklin, Gottingen, Germany
来源：
OPHTHALMOLOGE | 2017年 / 114卷 / 05期
关键词：
Subretinal hemorrhage; Coagulation; Vitrectomy; Visual deterioration; Intravitral injection; TISSUE-PLASMINOGEN ACTIVATOR; SUBMACULAR HEMORRHAGE; NATURAL-HISTORY; SUBRETINAL HEMORRHAGE; CO-APPLICATION; BEVACIZUMAB; COMPATIBILITY;
D O I：
10.1007/s00347-017-0487-x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Macular bleeding is associated with an acute loss of visual function and is frequently a complication of neovascular age-related macular degeneration. Blood degradation products can lead to permanent retinal neuronal damage over time. The extent of the bleeding is correlated to the coagulation status of the patient. The treatment strategy depends on the age, size and exact location of the bleeding. The spectrum of therapeutic options ranges from watchful waiting to large scale vitrectomy with removal of subretinal mass bleeding.
引用
收藏
页码：476 / 480
页数：5
相关论文
共 16 条
  • [1] Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration
    Avery, RL
    Fekrat, S
    Hawkins, BS
    Bressler, NM
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1996, 16 (03): : 183 - 189
  • [2] Bopp S, 2012, OPHTHALMOLOGE, V109, P635, DOI 10.1007/s00347-012-2563-6
  • [3] Feltgen N, 2012, OPHTHALMOLOGE, V109, P633, DOI 10.1007/s00347-012-2562-7
  • [4] EXPERIMENTAL SUB-RETINAL HEMORRHAGE IN RABBITS
    GLATT, H
    MACHEMER, R
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (06) : 762 - 773
  • [5] Hillenkamp J, 2012, OPHTHALMOLOGE, V109, P648, DOI 10.1007/s00347-012-2564-5
  • [6] EPIDEMIOLOGY OF THE ASSOCIATION BETWEEN ANTICOAGULANTS AND INTRAOCULAR HEMORRHAGE IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kiernan, Daniel F.
    Hariprasad, Seenu M.
    Rusu, Irene M.
    Mehta, Sahil V.
    Mieler, William F.
    Jager, Rama D.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1573 - 1578
  • [7] Compatibility of Recombinant Tissue Plasminogen Activator and Bevacizumab Co-Applied for Neovascular Age-Related Macular Degeneration With Submacular Hemorrhage
    Klettner, Alexa
    Puls, Svenja
    Treumer, Felix
    Roider, Johann
    Hillenkamp, Jost
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (07) : 875 - 881
  • [8] Subretinal Hemorrhages Associated with Age-Related Macular Degeneration in Patients Receiving Anticoagulation or Antiplatelet Therapy
    Kuhli-Hattenbach, Claudia
    Fischer, Ina Barbara
    Schalnus, Rainer
    Hattenbach, Lars-Olof
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (02) : 316 - 321
  • [9] The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator
    Lueke, Matthias
    Januschowski, Kai
    Warga, Max
    Beutel, Julia
    Leitritz, Martin
    Gelisken, Faik
    Grisanti, Salvatore
    Schneider, Toni
    Lueke, Christoph
    Bartz-Schmidt, Karl Ulrich
    Szurman, Peter
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (08) : 1077 - 1082
  • [10] POLINER LS, 1986, OPHTHALMOLOGY, V93, P543
12